dexa scan

GLP-1s Are Working — Now Medicine Needs to Measure What Matters

If we do not get this right, we may inadvertently cause a new sarcopenia epidemic while congratulating ourselves on solving obesity.

By Vivek Chander

Semaglutide weight loss drug, conceptual illustration. Marketed as Ozempic, semaglutide is a glucagon-like peptide-1 (GLP-1) analogue that is used to treat diabetes and for weight management. It increases the production of insulin, the hormone that lowers blood sugar levels, while also suppressing secretion of glucagon, the hormone that raises blood sugar levels. It also reduces hunger and slows gastric emptying

Beyond the Scale: How Imaging Can Help Determine GLP-1 Efficacy

Telehealth clinic Hone Health partnered with imaging company BodySpec to give its patients access to DEXA body composition scans. The partnership seeks to help providers and patients on GLP-1s distinguish fat loss from muscle loss and better evaluate how these drugs are affecting the body.

By Katie Adams

The Healthcare Payments Industry Faces a Perception Challenge

Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.

By Lisa Brooks, Vice President, Healthcare Partnerships

Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork

By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.

By Michael Blackman, MD, MBA Chief Medical Officer, Greenway Health®

Closing the Quality-Affordability Gap in Workplace Mental Health

In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable.

By Stephanie Baum